SlideShare ist ein Scribd-Unternehmen logo
1 von 14
Downloaden Sie, um offline zu lesen
University Institute for Cardiovascular Diseases, Belgrade, YUUniversity Institute for Cardiovascular Diseases, Belgrade, YU
PERICARDIOSCOPY ANDPERICARDIOSCOPY AND
PERICARDIAL BIOPSYPERICARDIAL BIOPSY
- Belgrade experience -- Belgrade experience -
Prof. Petar M. Seferović, MD, PhD, FESC, FACC
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
HISTORICAL OVERVIEWHISTORICAL OVERVIEW
♦ Initiated byInitiated by Santos and FraterSantos and Frater in 1977in 1977
♦ Flexible pericardioscopy -Flexible pericardioscopy - KondosKondos et al.et al. JACCJACC
19861986
♦ Transcutaneous approach in local anesthesia -Transcutaneous approach in local anesthesia -
MaischMaisch et al.et al. Eur Heart JEur Heart J 19911991
♦ Until nowUntil now implemented inimplemented in 16 centers16 centers
♦ OnlyOnly Marburg, Maryland and BelgradeMarburg, Maryland and Belgrade seriesseries
are dealing with non-surgicalare dealing with non-surgical,, transcutaneoustranscutaneous
approach in local anesthesiaapproach in local anesthesia
♦PE ofPE of unknown etiologyunknown etiology
♦PE in pts with knownPE in pts with known
malignancymalignancy
♦Verification ofVerification of perimyocarditisperimyocarditis
♦Verification ofVerification of tuberculoustuberculous
pericarditispericarditis
♦PBPPBP window verificationwindow verification
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
I N D I C A T I O N SI N D I C A T I O N S
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
AIM OF THE STUDYAIM OF THE STUDY
♦ TTo assess the feasibility and diagnostico assess the feasibility and diagnostic
value of three approaches to pericardialvalue of three approaches to pericardial
biopsy:biopsy:
1.1. FFluoroscopic controlluoroscopic control and standardand standard
samplingsampling
2.2. PPericardioscopyericardioscopy guidance with eitherguidance with either
standardstandard oror
3.3. EExtensive samplingxtensive sampling..
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
P A T I E N T SP A T I E N T S
PATIENTS N Males (%) Mean age
(yrs)
Evacuated PE
(ml)
Samples/pt
Group 1
(fluoroscopy)
12 66.7 46.7±12.2 775.0±171.2 3-6
Group 2
(pericardioscopy/
standard sampling)
22 50.0 50.8±10.4 769.5±185.7 4-6
Group 3
(pericardioscopy/
extensive sampling)
15 53.3 53.7±12.8 790.0±204.6 18-20
♦ SubxiphoidSubxiphoid
pericardiocentesispericardiocentesis andand
drainage of PEdrainage of PE
♦ Instillation of 200 ml salineInstillation of 200 ml saline
♦ 7F7F introducer-sheath setintroducer-sheath set
♦ Position at thePosition at the upper leftupper left
laterallateral surface of thesurface of the
parietal pericardiumparietal pericardium
♦ OlympusOlympus FB-43ST forcepsFB-43ST forceps
(fenestrated, central needle)(fenestrated, central needle)
♦ 4-6 samples4-6 samples (mean 5.1)(mean 5.1)
Pericardial Biopsy Using FluoroscopyPericardial Biopsy Using Fluoroscopy
M E T H O DM E T H O D
N=12 pts (group 1)
♦ SubxiphoidSubxiphoid pericardiocentesispericardiocentesis
and drainage of PEand drainage of PE
♦ LLocal anesthesiaocal anesthesia
♦ Olympus HYF-1Olympus HYF-1TT, 16F, 16F
flexible endoscopeflexible endoscope
♦ GGradual dilationradual dilation (9(9,, 12, 14F12, 14F))
up toup to 16.5F introducer-set16.5F introducer-set
♦ PericardialPericardial biopsy targeted bybiopsy targeted by
pericardioscopypericardioscopy ((OlympusOlympus
FB-43ST forceps )FB-43ST forceps )
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
M E T H O DM E T H O D
N=37 pts (groups 2 & 3)
Flexible percutaneous pericardioscopyFlexible percutaneous pericardioscopy
BELGRADE METHODOLOGYBELGRADE METHODOLOGY
MODIFICATIONSMODIFICATIONS
(Seferovic PM, et al. Herz 2000)(Seferovic PM, et al. Herz 2000)
♦ Olympus HYF-1T, 16FOlympus HYF-1T, 16F
flexible endoscope (flexible endoscope (biopsybiopsy
channel 2.2 mmchannel 2.2 mm))
♦ Active pericardial drainageActive pericardial drainage
♦ Intrapericardial instillationIntrapericardial instillation
of 100-300 ml of airof 100-300 ml of air
♦ AIMED BIOPSYAIMED BIOPSY
♦ EXTENSIVE SAMPLINGEXTENSIVE SAMPLING
(up to 20 samples/pt)(up to 20 samples/pt)
♦ Pericardioscopy after PBPPericardioscopy after PBP
MACROSCOPICMACROSCOPIC
PERICARDIOSCOPY FINDINGSPERICARDIOSCOPY FINDINGS
(Seferovic PM, et al. Herz 2000)(Seferovic PM, et al. Herz 2000)
Pericardioscopy
macroscopic
findings
Neoplastic
pericardits
(n=10 pts)
Nonspecific
inflammatory
pericarditis
(n=7 pts)
Tuberculous
pericarditis
(n=3 pts)
Adhesion strands 4 (40%) 2 (28.6%) 1 (33.3%)
Massive adhesions 2 (20%) 0 1 (33.3%)
Fibrin deposition 2 (20%) 4 (57.1%) 1 (33.3%)
Vascular injections 8 (80%) 7 (100%) 2 (66.7%)
Areas of hyperemia 6 (60%) 6 (85.7%) 2 (66.7%)
Infiltration 7 (70%) 1 (14.3%) 1 (33.3%)
Protrusions 6 (60%) 0 1 (33.3%)
all p>0.05
Olympus
FB-43ST Biopsy
Forceps
Group 1
(12 patients)
Fluoroscopy
3-6 samples
Group 2
(22 patients)
Pericardioscopy
4-6 samples
Group 3
(15 patients)
Pericardioscopy
18-20 samples
Feasibility of
pericardial access
92.8% 96.2% 100%
Feasibility of sheath
introduction
92.3% 96.0% 100%
Adequate pericardial
visualization
Not applicable 90.9% 93.3%
Sampling efficiency 43.7% 84.9%** 84.2%**
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
FEASIBILITY AND SAMPLINGFEASIBILITY AND SAMPLING
EFFICIENCYEFFICIENCY
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
SAMPLING EFFICIENCY /SAMPLING EFFICIENCY /
SENSITIVITYSENSITIVITY
43.7
84.9
84.2
41.7
63.6
93.3
Group 1 (fluoroscopy, 12 pts, 3-6 samples/pt)
Group 2 (pericardioscopy, 22 pts, 4-6 samples/pt)
Group 3 (pericardioscopy, 15 pts, 18-20 samples/pt
0 20 40 60 80Sampling efficiency Sensitivity
**
**
**
(%)
Pathohistology Group 1
(12 patients)
Fluoroscopy
3-6 samples
Group 2
(22 patients)
Pericardioscopy
4-6 samples
Group 3
(15 patients)
Pericardioscopy
18-20 samples
Planocellular Ca 1 (8.3%) 3 (13.6%) 13.3 %
Adenocarcinoma 0 3 (13.6%) 6.7%
Mesothelioma 0 0 6.7%
Plasmocytoma 0 1 (4.5%) 0
Hodgkin’s disease 0 1 (4.5%) 6.7%
Tuberculosis 0 1 (4.5%) 20 %
Nonspecific
inflammation
4 (33.3%) 5 (22.7%) 40 %
False negative 58.3 36.4 6.7**
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
HISTOLOGYHISTOLOGY
8.3 8.3
33.3
58.3
26.3
40.9
36.4
36.440
53.3 53.3
6.7
New Dg. Etiology Clin.Dg.confirmed No useful information
0
20
40
60
80
100
%
Fluoroscopic biopsy (3-6 samples)
Pericardioscopy (3-6 samples)
Pericardioscopy (18-20 samples)
* *
* *
DIAGNOSTIC VALUE OFDIAGNOSTIC VALUE OF
PERICARDIOSCOPYPERICARDIOSCOPY ANDAND
PERICARDIAL BIOPSYPERICARDIAL BIOPSY
♦ Excellent visualizationExcellent visualization but nonspecificbut nonspecific
macroscopic findingsmacroscopic findings..
♦ Pericardioscopic guidancePericardioscopic guidance enhancedenhanced
pericardial sampling efficiency.pericardial sampling efficiency.
♦ TheThe diagnostic value of pericardial biopsydiagnostic value of pericardial biopsy
was significantly improved by extensivewas significantly improved by extensive
samplingsampling made possible by pericardioscopy.made possible by pericardioscopy.
Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy
CONCLUSIONSCONCLUSIONS

Más contenido relacionado

Was ist angesagt?

Was ist angesagt? (15)

058 optical coherence tomography
058 optical coherence tomography058 optical coherence tomography
058 optical coherence tomography
 
Optical coherence tomography optical biopsy with a short photonic needle
Optical coherence tomography optical biopsy with a short photonic needleOptical coherence tomography optical biopsy with a short photonic needle
Optical coherence tomography optical biopsy with a short photonic needle
 
Oct with shourt phontonic needle
Oct with shourt phontonic needleOct with shourt phontonic needle
Oct with shourt phontonic needle
 
OCT ANGIOGRAPHY
OCT ANGIOGRAPHYOCT ANGIOGRAPHY
OCT ANGIOGRAPHY
 
03 aimradial2016 fri Y Ikari
03 aimradial2016 fri Y Ikari03 aimradial2016 fri Y Ikari
03 aimradial2016 fri Y Ikari
 
Oct angiography
Oct angiographyOct angiography
Oct angiography
 
Oct angiography topcon leaflet may 2015
Oct angiography topcon leaflet  may 2015Oct angiography topcon leaflet  may 2015
Oct angiography topcon leaflet may 2015
 
Nuclear medicine in dento maxillofacial region
Nuclear medicine in dento maxillofacial regionNuclear medicine in dento maxillofacial region
Nuclear medicine in dento maxillofacial region
 
OCT ANGIOGRAPHY
OCT ANGIOGRAPHYOCT ANGIOGRAPHY
OCT ANGIOGRAPHY
 
Improvements in brain tumor surgery
Improvements in brain tumor surgeryImprovements in brain tumor surgery
Improvements in brain tumor surgery
 
Optovue OCT-A quick review
Optovue OCT-A quick reviewOptovue OCT-A quick review
Optovue OCT-A quick review
 
Prospective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liverProspective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liver
 
Laparoscopic aortic surgery
Laparoscopic aortic  surgeryLaparoscopic aortic  surgery
Laparoscopic aortic surgery
 
Endoleaks 1, 3
Endoleaks 1, 3Endoleaks 1, 3
Endoleaks 1, 3
 
Intravascular mri diagnostic and therapeutic potentials
Intravascular mri diagnostic and therapeutic potentialsIntravascular mri diagnostic and therapeutic potentials
Intravascular mri diagnostic and therapeutic potentials
 

Ähnlich wie Seferovic

Git j club EUS FNA or cb.
Git j club EUS FNA or cb.Git j club EUS FNA or cb.
Git j club EUS FNA or cb.Shaikhani.
 
ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...
ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...
ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...Salvatore Ronsivalle
 
2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...
2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...
2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...Centro Diagnostico Nardi
 
Endoscopic Parathyroid Surgery
Endoscopic Parathyroid SurgeryEndoscopic Parathyroid Surgery
Endoscopic Parathyroid SurgeryGeorge S. Ferzli
 
5 Liver Fibrosis Assessment Dr. V.G. Mohanprasad
5 Liver Fibrosis Assessment Dr. V.G. Mohanprasad5 Liver Fibrosis Assessment Dr. V.G. Mohanprasad
5 Liver Fibrosis Assessment Dr. V.G. Mohanprasadrrsolution
 
Vgn cfhennai isg-2015_latest new final _
Vgn   cfhennai isg-2015_latest new final _Vgn   cfhennai isg-2015_latest new final _
Vgn cfhennai isg-2015_latest new final _rrsolution
 
Pitfalls in Performing and Interpreting IPSS 2021.pdf
Pitfalls in Performing and Interpreting IPSS 2021.pdfPitfalls in Performing and Interpreting IPSS 2021.pdf
Pitfalls in Performing and Interpreting IPSS 2021.pdffrancisco551255
 
Renal biopsy seminar
Renal biopsy seminarRenal biopsy seminar
Renal biopsy seminarVishal Golay
 
Endoscopia in veglia versus in sonno la nostra esperienza in 250 pazienti
Endoscopia in veglia versus in sonno la nostra esperienza in 250 pazientiEndoscopia in veglia versus in sonno la nostra esperienza in 250 pazienti
Endoscopia in veglia versus in sonno la nostra esperienza in 250 pazientiMerqurio
 
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...Centro Diagnostico Nardi
 
The place of baseline biopsy histology
The place of baseline biopsy histology The place of baseline biopsy histology
The place of baseline biopsy histology Maarten Naesens
 
Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...
Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...
Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...Alex Swanton
 
Endovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experienceEndovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experienceGeorge Trellopoulos
 
Castera élastométrie:pbh du16
Castera  élastométrie:pbh du16Castera  élastométrie:pbh du16
Castera élastométrie:pbh du16odeckmyn
 
Presentation Monica Stoian
Presentation Monica StoianPresentation Monica Stoian
Presentation Monica StoianMihaiela Fazacas
 
Microdissection testicular sperm extraction
Microdissection testicular sperm extractionMicrodissection testicular sperm extraction
Microdissection testicular sperm extractionSandro Esteves
 
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...Centro Diagnostico Nardi
 

Ähnlich wie Seferovic (20)

Git j club EUS FNA or cb.
Git j club EUS FNA or cb.Git j club EUS FNA or cb.
Git j club EUS FNA or cb.
 
ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...
ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...
ALISEO Treatment Of Iatrogenic Artery Pseudoaneurysm By Ultrasound Guided Fib...
 
Azoospermia
Azoospermia Azoospermia
Azoospermia
 
Pancoronary therapy with ipdd
Pancoronary therapy with ipddPancoronary therapy with ipdd
Pancoronary therapy with ipdd
 
2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...
2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...
2006 cortona, congresso tosco umbro. ablazione ne i trattamento ablativo dell...
 
Endoscopic Parathyroid Surgery
Endoscopic Parathyroid SurgeryEndoscopic Parathyroid Surgery
Endoscopic Parathyroid Surgery
 
5 Liver Fibrosis Assessment Dr. V.G. Mohanprasad
5 Liver Fibrosis Assessment Dr. V.G. Mohanprasad5 Liver Fibrosis Assessment Dr. V.G. Mohanprasad
5 Liver Fibrosis Assessment Dr. V.G. Mohanprasad
 
Vgn cfhennai isg-2015_latest new final _
Vgn   cfhennai isg-2015_latest new final _Vgn   cfhennai isg-2015_latest new final _
Vgn cfhennai isg-2015_latest new final _
 
Pitfalls in Performing and Interpreting IPSS 2021.pdf
Pitfalls in Performing and Interpreting IPSS 2021.pdfPitfalls in Performing and Interpreting IPSS 2021.pdf
Pitfalls in Performing and Interpreting IPSS 2021.pdf
 
Renal biopsy seminar
Renal biopsy seminarRenal biopsy seminar
Renal biopsy seminar
 
Endoscopia in veglia versus in sonno la nostra esperienza in 250 pazienti
Endoscopia in veglia versus in sonno la nostra esperienza in 250 pazientiEndoscopia in veglia versus in sonno la nostra esperienza in 250 pazienti
Endoscopia in veglia versus in sonno la nostra esperienza in 250 pazienti
 
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
2006 terni, workshop interattivo. la terapia ablativa percutanea della fibril...
 
The place of baseline biopsy histology
The place of baseline biopsy histology The place of baseline biopsy histology
The place of baseline biopsy histology
 
Patent foramen ovale
Patent foramen ovalePatent foramen ovale
Patent foramen ovale
 
Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...
Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...
Azoospermia: Is Sample Centrifugation Indicated? A National Survey of Practic...
 
Endovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experienceEndovascular repair of traumatic aortic transection six years of experience
Endovascular repair of traumatic aortic transection six years of experience
 
Castera élastométrie:pbh du16
Castera  élastométrie:pbh du16Castera  élastométrie:pbh du16
Castera élastométrie:pbh du16
 
Presentation Monica Stoian
Presentation Monica StoianPresentation Monica Stoian
Presentation Monica Stoian
 
Microdissection testicular sperm extraction
Microdissection testicular sperm extractionMicrodissection testicular sperm extraction
Microdissection testicular sperm extraction
 
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
2007 pizzo calabro, convegno regionale anmco. quale approccio ablativo nella ...
 

Mehr von Society for Heart Attack Prevention and Eradication

Mehr von Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi PresentationAHA SHAPE Symposium 2017 Dr. Naghavi Presentation
AHA SHAPE Symposium 2017 Dr. Naghavi Presentation
 
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka PresentationAHA SHAPE Symposium 2017 Dr. Slomka Presentation
AHA SHAPE Symposium 2017 Dr. Slomka Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 

Último

Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedSBL DIGITAL
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersSai Sailesh Kumar Goothy
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHUKanhu Charan
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......anupamdas2143
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONojaswinihemane
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptxMrStavanUdayKadam
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfMayuriGamit2
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxTina Purnat
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdfHongBiThi1
 
bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhanthesalberry
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptxtusharchokshi1
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 

Último (20)

Derma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech LimitedDerma Pharmaceutical Franchise Company - Solace Biotech Limited
Derma Pharmaceutical Franchise Company - Solace Biotech Limited
 
Thyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disordersThyroid hormones- synthesis, secretion, functions and disorders
Thyroid hormones- synthesis, secretion, functions and disorders
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM  CANCER BY DR KANHUTARGET DELINEATION IN RECTUM  CANCER BY DR KANHU
TARGET DELINEATION IN RECTUM CANCER BY DR KANHU
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......
 
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
Catalysts for Change in SCLC: Optimizing the Use of Standard Therapies and Ac...
 
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTIONANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
ANTIPERSPIRANTS AND DEODORANTS : MECHANISM OF ACTION
 
CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptx
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
Oral disorders .pptx
Oral disorders .pptxOral disorders .pptx
Oral disorders .pptx
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptx
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
 
bleeding disorders 1 Dr.Nannika Pradhan
bleeding disorders 1  Dr.Nannika Pradhanbleeding disorders 1  Dr.Nannika Pradhan
bleeding disorders 1 Dr.Nannika Pradhan
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptx
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 

Seferovic

  • 1. University Institute for Cardiovascular Diseases, Belgrade, YUUniversity Institute for Cardiovascular Diseases, Belgrade, YU PERICARDIOSCOPY ANDPERICARDIOSCOPY AND PERICARDIAL BIOPSYPERICARDIAL BIOPSY - Belgrade experience -- Belgrade experience - Prof. Petar M. Seferović, MD, PhD, FESC, FACC
  • 2. Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy HISTORICAL OVERVIEWHISTORICAL OVERVIEW ♦ Initiated byInitiated by Santos and FraterSantos and Frater in 1977in 1977 ♦ Flexible pericardioscopy -Flexible pericardioscopy - KondosKondos et al.et al. JACCJACC 19861986 ♦ Transcutaneous approach in local anesthesia -Transcutaneous approach in local anesthesia - MaischMaisch et al.et al. Eur Heart JEur Heart J 19911991 ♦ Until nowUntil now implemented inimplemented in 16 centers16 centers ♦ OnlyOnly Marburg, Maryland and BelgradeMarburg, Maryland and Belgrade seriesseries are dealing with non-surgicalare dealing with non-surgical,, transcutaneoustranscutaneous approach in local anesthesiaapproach in local anesthesia
  • 3. ♦PE ofPE of unknown etiologyunknown etiology ♦PE in pts with knownPE in pts with known malignancymalignancy ♦Verification ofVerification of perimyocarditisperimyocarditis ♦Verification ofVerification of tuberculoustuberculous pericarditispericarditis ♦PBPPBP window verificationwindow verification Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy I N D I C A T I O N SI N D I C A T I O N S
  • 4. Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy AIM OF THE STUDYAIM OF THE STUDY ♦ TTo assess the feasibility and diagnostico assess the feasibility and diagnostic value of three approaches to pericardialvalue of three approaches to pericardial biopsy:biopsy: 1.1. FFluoroscopic controlluoroscopic control and standardand standard samplingsampling 2.2. PPericardioscopyericardioscopy guidance with eitherguidance with either standardstandard oror 3.3. EExtensive samplingxtensive sampling..
  • 5. Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy P A T I E N T SP A T I E N T S PATIENTS N Males (%) Mean age (yrs) Evacuated PE (ml) Samples/pt Group 1 (fluoroscopy) 12 66.7 46.7±12.2 775.0±171.2 3-6 Group 2 (pericardioscopy/ standard sampling) 22 50.0 50.8±10.4 769.5±185.7 4-6 Group 3 (pericardioscopy/ extensive sampling) 15 53.3 53.7±12.8 790.0±204.6 18-20
  • 6. ♦ SubxiphoidSubxiphoid pericardiocentesispericardiocentesis andand drainage of PEdrainage of PE ♦ Instillation of 200 ml salineInstillation of 200 ml saline ♦ 7F7F introducer-sheath setintroducer-sheath set ♦ Position at thePosition at the upper leftupper left laterallateral surface of thesurface of the parietal pericardiumparietal pericardium ♦ OlympusOlympus FB-43ST forcepsFB-43ST forceps (fenestrated, central needle)(fenestrated, central needle) ♦ 4-6 samples4-6 samples (mean 5.1)(mean 5.1) Pericardial Biopsy Using FluoroscopyPericardial Biopsy Using Fluoroscopy M E T H O DM E T H O D N=12 pts (group 1)
  • 7. ♦ SubxiphoidSubxiphoid pericardiocentesispericardiocentesis and drainage of PEand drainage of PE ♦ LLocal anesthesiaocal anesthesia ♦ Olympus HYF-1Olympus HYF-1TT, 16F, 16F flexible endoscopeflexible endoscope ♦ GGradual dilationradual dilation (9(9,, 12, 14F12, 14F)) up toup to 16.5F introducer-set16.5F introducer-set ♦ PericardialPericardial biopsy targeted bybiopsy targeted by pericardioscopypericardioscopy ((OlympusOlympus FB-43ST forceps )FB-43ST forceps ) Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy M E T H O DM E T H O D N=37 pts (groups 2 & 3)
  • 8. Flexible percutaneous pericardioscopyFlexible percutaneous pericardioscopy BELGRADE METHODOLOGYBELGRADE METHODOLOGY MODIFICATIONSMODIFICATIONS (Seferovic PM, et al. Herz 2000)(Seferovic PM, et al. Herz 2000) ♦ Olympus HYF-1T, 16FOlympus HYF-1T, 16F flexible endoscope (flexible endoscope (biopsybiopsy channel 2.2 mmchannel 2.2 mm)) ♦ Active pericardial drainageActive pericardial drainage ♦ Intrapericardial instillationIntrapericardial instillation of 100-300 ml of airof 100-300 ml of air ♦ AIMED BIOPSYAIMED BIOPSY ♦ EXTENSIVE SAMPLINGEXTENSIVE SAMPLING (up to 20 samples/pt)(up to 20 samples/pt) ♦ Pericardioscopy after PBPPericardioscopy after PBP
  • 9. MACROSCOPICMACROSCOPIC PERICARDIOSCOPY FINDINGSPERICARDIOSCOPY FINDINGS (Seferovic PM, et al. Herz 2000)(Seferovic PM, et al. Herz 2000) Pericardioscopy macroscopic findings Neoplastic pericardits (n=10 pts) Nonspecific inflammatory pericarditis (n=7 pts) Tuberculous pericarditis (n=3 pts) Adhesion strands 4 (40%) 2 (28.6%) 1 (33.3%) Massive adhesions 2 (20%) 0 1 (33.3%) Fibrin deposition 2 (20%) 4 (57.1%) 1 (33.3%) Vascular injections 8 (80%) 7 (100%) 2 (66.7%) Areas of hyperemia 6 (60%) 6 (85.7%) 2 (66.7%) Infiltration 7 (70%) 1 (14.3%) 1 (33.3%) Protrusions 6 (60%) 0 1 (33.3%) all p>0.05
  • 10. Olympus FB-43ST Biopsy Forceps Group 1 (12 patients) Fluoroscopy 3-6 samples Group 2 (22 patients) Pericardioscopy 4-6 samples Group 3 (15 patients) Pericardioscopy 18-20 samples Feasibility of pericardial access 92.8% 96.2% 100% Feasibility of sheath introduction 92.3% 96.0% 100% Adequate pericardial visualization Not applicable 90.9% 93.3% Sampling efficiency 43.7% 84.9%** 84.2%** Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy FEASIBILITY AND SAMPLINGFEASIBILITY AND SAMPLING EFFICIENCYEFFICIENCY
  • 11. Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy SAMPLING EFFICIENCY /SAMPLING EFFICIENCY / SENSITIVITYSENSITIVITY 43.7 84.9 84.2 41.7 63.6 93.3 Group 1 (fluoroscopy, 12 pts, 3-6 samples/pt) Group 2 (pericardioscopy, 22 pts, 4-6 samples/pt) Group 3 (pericardioscopy, 15 pts, 18-20 samples/pt 0 20 40 60 80Sampling efficiency Sensitivity ** ** ** (%)
  • 12. Pathohistology Group 1 (12 patients) Fluoroscopy 3-6 samples Group 2 (22 patients) Pericardioscopy 4-6 samples Group 3 (15 patients) Pericardioscopy 18-20 samples Planocellular Ca 1 (8.3%) 3 (13.6%) 13.3 % Adenocarcinoma 0 3 (13.6%) 6.7% Mesothelioma 0 0 6.7% Plasmocytoma 0 1 (4.5%) 0 Hodgkin’s disease 0 1 (4.5%) 6.7% Tuberculosis 0 1 (4.5%) 20 % Nonspecific inflammation 4 (33.3%) 5 (22.7%) 40 % False negative 58.3 36.4 6.7** Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy HISTOLOGYHISTOLOGY
  • 13. 8.3 8.3 33.3 58.3 26.3 40.9 36.4 36.440 53.3 53.3 6.7 New Dg. Etiology Clin.Dg.confirmed No useful information 0 20 40 60 80 100 % Fluoroscopic biopsy (3-6 samples) Pericardioscopy (3-6 samples) Pericardioscopy (18-20 samples) * * * * DIAGNOSTIC VALUE OFDIAGNOSTIC VALUE OF PERICARDIOSCOPYPERICARDIOSCOPY ANDAND PERICARDIAL BIOPSYPERICARDIAL BIOPSY
  • 14. ♦ Excellent visualizationExcellent visualization but nonspecificbut nonspecific macroscopic findingsmacroscopic findings.. ♦ Pericardioscopic guidancePericardioscopic guidance enhancedenhanced pericardial sampling efficiency.pericardial sampling efficiency. ♦ TheThe diagnostic value of pericardial biopsydiagnostic value of pericardial biopsy was significantly improved by extensivewas significantly improved by extensive samplingsampling made possible by pericardioscopy.made possible by pericardioscopy. Pericardioscopy and Pericardial BiopsyPericardioscopy and Pericardial Biopsy CONCLUSIONSCONCLUSIONS